Neuroblastoma Therapeutic Market is Anticipated to Witness Significant Growth owing to Rising Incidence Rates of Neuroblastoma Globally



Neuroblastoma therapeutic is a cancer that develops from immature nerve cells found in several areas of the body, primarily the adrenal glands, chest, and neck. Neuroblastoma therapeutics are used to treat neuroblastoma and include different types of drugs such as chemotherapy drugs, immunotherapy drugs, targeted therapy drugs, tumor vaccines, and radiation therapy. The neuroblastoma therapeutic market encompasses drugs that target neuroblastoma at various stages of disease progression. Global spending on neuroblastoma therapeutics is rising in tandem with increasing awareness regarding neuroblastoma treatment options and early diagnosis.

The Global Neuroblastoma Therapeutic Market is estimated to be valued at US$ 2.78 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024-2031.

Key Takeaways
Key players operating in the Neuroblastoma Therapeutic market are United Therapeutics, AUM Biosciences, Cellectar Biosciences, Y-mAbs Therapeutics, Seagen Inc. United Therapeutics' UNITUXIN (dinutuximab) is a monoclonal antibody used for high-risk neuroblastoma treatment. AUM Biosciences' AU-011 is an investigational product that is a chimeric monoclonal antibody under clinical trials for relapsed neuroblastoma treatment.

The key opportunities in the neuroblastoma therapeutic market include growing R&D investments from pharmaceutical companies, emerging pipeline drugs, and development of combination therapies. The adoption of targeted drugs and immunotherapies holds promise to revolutionize neuroblastoma treatment landscape.

Major players are expanding their global presence by establishing manufacturing and distribution networks across different regions. For instance, United Therapeutics acquired worldwide rights to dinutuximab from EUSA Pharma and is strengthening its commercialization in international markets. Cellectar Biosciences also plans to expand dinutuximab program in Europe.

Market drivers
One of the key drivers for the neuroblastoma therapeutics market is the rising disease incidence globally. Neuroblastoma is the most common cancer in infants, with over 700 new cases diagnosed in the U.S. each year. Its high mortality rate warrants development of improved treatment options.

Market restraints
High costs of targeted drugs and immunotherapies remain a major market barrier, limiting their widespread adoption in low and middle-income nations. Neuroblastoma mainly affects young children, making the economic burden overwhelming for families in developing countries. This reduces the commercial potential of novel high-priced therapeutics in those markets.


Segment Analysis
The neuroblastoma therapeutics market can be segmented based on therapy, distribution channel, and region. By therapy, the market is divided into chemotherapy, immunotherapy, targeted therapy, and others. The chemotherapy segment currently dominates the market due to wide usage and availability of chemotherapy drugs for neuroblastoma treatment. However, the targeted therapy segment is expected to grow at the fastest pace during the forecast period. This is attributed to the ongoing development of targeted drugs and rising focus on precision medicine for various cancers including neuroblastoma. By distribution channel, the market is classified as hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment holds the largest share as neuroblastoma treatments are commonly administered in hospitals.

Global Analysis
Regionally, North America is expected to dominate the global neuroblastoma therapeutics market during the forecast period. This is due to the rising prevalence of neuroblastoma in the US, growing healthcare expenditure, availability of advanced treatments, and presence of major players in the region. However, Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period. This is attributed to growing awareness regarding neuroblastoma in developing countries, rising healthcare expenditure, and expansion of key market players in emerging Asia Pacific countries.

Get more insights on this topic : https://justpaste.it/i3oit

What Are The Key Data Covered In This Neuroblastoma Therapeutic Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Neuroblastoma Therapeutic's growth between 2024 and 2031.

:- Accurate calculation of the size of the Neuroblastoma Therapeutic and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Neuroblastoma Therapeutic Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Neuroblastoma Therapeutic vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Comments

Post a Comment

Popular posts from this blog

Laser Projection Market is to Witness High Growth Owing to Advancements in RGB Laser Projection Technology

Image
  The laser projection market involves the usage of laser diodes and phosphor wheels to project images instead of traditional light bulbs and rotating color wheels. Laser projection technology offers a variety of benefits over conventional projection including high brightness levels, long lifespan, high resolutions, and high contrast ratios. Laser projectors are increasingly being used for entertainment and commercial applications such as cinemas, digital signage, and conferences & seminars. The demand for   Laser Projection Market is driven by the superior image quality, higher resolutions and brighter images they provide compared to conventional projectors. The laser projection market is estimated to be valued at   USD 17.52 Bn in 2024   and is expected to reach   USD 56.28 Bn by 2031,  growing at a compound annual growth rate  (CAGR) of 18.1% from 2024 to 2031.  Key Takeaways Key players: Key players operating in the laser projection...
Read more

AL Amyloidosis Diagnostics is to Witness High Growth due to Advancements in Molecular Diagnostics and Flow Cytometry

Image
AL amyloidosis, also called primary (AL) amyloidosis, is a plasma cell disorder characterized by the buildup of abnormal protein deposits known as amyloid in tissues and organs. AL amyloidosis can affect the heart, kidneys, liver, nervous system, and digestive system. Early and precise diagnosis of AL Amyloidosis Diagnostics Market is very important for effective treatment and management of the disease. The AL amyloidosis diagnostic market is estimated to be valued at  USD 1.068 billion in 2024   and is expected to reach   USD 1.693 billion by 2031 , growing at a compound annual growth rate   (CAGR) of 6.8% from 2024 to 2031. Key Takeaways Key players operating in the AL amyloidosis diagnostics are Siemens Healthineers, Abbott Laboratories, IMMUNOConcepts, PrognostiX, Ark Diagnostics. The key opportunities in the AL amyloidosis diagnostics market include development of minimally invasive diagnostic techniques, adoption of PET imaging for diagnosis, advanceme...
Read more

Navigating the Stuttering Treatment Market: Top Solutions for Effective Speech Therapy

Image
The stuttering treatment market involves speech therapy techniques that help reduce or eliminate stuttering or stammering symptoms. Stuttering or stammering occurs when the flow of speech is disrupted by involuntary blocking, repetition, or prolongation of certain sounds. Such involuntary disruptions create difficulties in expressing thoughts fluently which can negatively impact an individual's self-confidence and social interactions. The need for effective Stuttering Market treatment solutions is rising due to the availability of advanced methods such as modified fluency shaping techniques, delayed auditory feedback devices, and self-therapy programs. The Global Stuttering Market is estimated to be valued at   USD 51.5 million in 2024   and is expected to reach   USD 150.1 million by 2031 , growing at a compound annual growth rate   (CAGR) of 11.3% from 2024 to 2031. Key Takeaways Key players operating in the stuttering treatment market are Johnson & Johns...
Read more